Smart science to improve lives™
Open search Basket 0 View basket
Pharma

Explore our latest available downloads...

Explore Croda Pharmas resource area

Excipients in parenteral drug delivery - Injectable delivery of Small Molecules

Discover our latest literature highlighting our high purity excipients used in the parenteral delivery of small molecule drugs. Included in our latest brochure are our lipid offerings.

Lipids play a pivotal role in enhancing the parenteral delivery of small molecule APIs by facilitating the formation of liposomes while Liposomes provide a stable and biocompatible carrier system for the encapsulation and solubilization of both hydrophobic and hydrophilic drug compounds.

This unique capability not only improves the drug's bioavailability but also ensures a controlled and sustained release, optimising therapeutic outcomes. Liposomal drug delivery has shown proven efficacy in various small molecule applications, including: pain management drugs, cancer therapies and more...

The ability of liposomes to encapsulate drugs makes them an ideal choice for targeted delivery, addressing the specific challenges associated with these critical therapeutic areas. Our commitment to advancing cutting edge science supports the development of medicines, empowering formulators with reliable solutions for developing next-generation therapies

Injectable delivery of small molecules flyer

Croda Pharma flyer - Injectables for small molecules
288.3 KB

Vaccines for a more sustainable future whitepaper

Confronting the challenge and impact of climate change is all around us and it's equally important that this is considered when in the development of novel vaccines. If we continually tap into nature’s resources in an unsustainable way, we will inevitably run out.
 
We can all contribute to not only select sustainable ingredients, but to secure supply chains and sources that will not deplete in the future. We discuss this in our latest white paper: Vaccines for a more sustainable future.

We must take every possible step to safeguard our planet as we strive for a sustainable future. A nature-positive approach empowers our planet and communities. It's a revolutionary concept that challenges us to reimagine our role on Earth, by acting to positively impact biodiversity and the natural environment.
 
Yet, confronting this challenge isn't limited to only addressing climate issues; we must extend our efforts to embrace and protect nature as well.

EXCLUSIVE WHITEPAPER: Vaccines for a more sustainable future

Download Croda Pharmas new whitepaper, Vaccines for a sustainable future
335.1 KB

Explore recent blogs:

manufacturing pd

QbD Formulation Development

Formulation development is a pivotal stage in the life cycle of a therapeutic drug product, it can be the make or break of it. The goal of formulation development is to convert active substance (drug...
green washed depiction of an LNP

Targeted lipid nanoparticles in Nucleic Acid Delivery

Targeted lipid nanoparticles (tLNPs) enhance the precision and efficacy of delivering a variety of therapeutic agents including nucleic acids to specific tissues and cell populations, thereby...
Blue washed image of female in the lab

Croda joins CGT Catapult consortium to improve AAV formulation

The Cell and Gene Therapy Catapult (CGT Catapult) has established a cross-industry consortium to improve the understanding and process optimisation of adeno-associated virus (AAV) formulation.
man in a lab looking at results

Synthesis, characterisation and degradation of polysorbates in biopharmaceuticals

Polysorbates are essential in biologics delivery, serving as crucial emulsifiers and stabilisers for biopharmaceuticals. They enhance solubility, improve bioavailability, and protect proteins from...